$XLRN ACCELERON PHARMA INC Insider Trading
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ACCELERON PHARMA INC for free.
CIK Number: 0001280600
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: XLRN
Company Address: 128 SIDNEY STREET CAMBRIDGE 02139
Phone number: 617-649-9200
Market Capitalization: $879.48M
Prev close: $23.74
Average Daily Volume: 430,577
Days Low: $23.07
Year Low: $22.67
Year High: $41.69
ACCELERON PHARMA INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2021 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Payment of Exercise | F | 126.69 | 108 | 13,683 | 20,923 | 21 K to 20.9 K (-0.51 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 40.61 | 7,500 | 304,575 | 0 | |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 121.23 | 200 | 24,246 | 6,044 | 6.2 K to 6 K (-3.20 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 120.16 | 1,143 | 137,343 | 6,244 | 7.4 K to 6.2 K (-15.47 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 119.36 | 4,030 | 481,021 | 7,387 | 11.4 K to 7.4 K (-35.30 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 118.39 | 2,127 | 251,816 | 11,417 | 13.5 K to 11.4 K (-15.70 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 40.61 | 7,500 | 304,575 | 13,544 | 6 K to 13.5 K (+124.09 %) |
Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | M | 24.11 | 10,000 | 241,100 | 0 | |
Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 142.27 | 1,100 | 156,497 | 34,499 | 35.6 K to 34.5 K (-3.09 %) |
Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 141.28 | 2,152 | 304,035 | 35,599 | 37.8 K to 35.6 K (-5.70 %) |
Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 140.31 | 6,748 | 946,812 | 37,751 | 44.5 K to 37.8 K (-15.16 %) |
Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | M | 24.11 | 10,000 | 241,100 | 44,499 | 34.5 K to 44.5 K (+28.99 %) |
Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Option Exercise | M | 52.99 | 2,050 | 108,630 | 4,085 | |
Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Option Exercise | M | 41.64 | 1,875 | 78,075 | 3,750 | |
Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Option Exercise | M | 35.34 | 5,000 | 176,700 | 10,000 |